4.8 Article

How GRAIL controls Treg function to maintain self-tolerance

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

The ubiquitin ligase Cul5 regulates CD4+ T cell fate choice and allergic inflammation

Binod Kumar et al.

Summary: The absence of E3 ubiquitin ligase Cul5 in T cells leads to abnormal development of T(H)2 and T(H)9 cells, resulting in increased secretion of allergy-associated factors IL-4 and IL-9, which are associated with the occurrence of allergic asthma.

NATURE COMMUNICATIONS (2022)

Review Immunology

Regulatory T Cells, a Viable Target Against Airway Allergic Inflammatory Responses in Asthma

Jing Zhang et al.

Summary: Asthma is a multifactorial disorder characterized by chronic inflammation, hyper-responsiveness, remodeling, and reversible obstruction. Recent studies suggest that most cases are Th2-high type and regulatory T cells (Tregs) play an essential role in limiting the development of allergic diseases. Researchers are exploring new treatment methods based on Tregs.

FRONTIERS IN IMMUNOLOGY (2022)

Article Allergy

Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases-An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)

Franziska Roth-Walter et al.

Summary: Therapeutic advances using targeted biologicals and small-molecule drugs have achieved significant success in treating chronic inflammatory and autoimmune diseases, especially for some severe, treatment-resistant forms. T cell-based therapies aim to cure diseases by delivering engineered specific cytotoxic or regulatory T cells, revolutionizing the field of oncology and offering potential curative options for immune-driven disorders.

ALLERGY (2021)

Review Immunology

Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases

Hanna Grasshoff et al.

Summary: Regulatory T cells (Treg) are crucial for maintaining peripheral tolerance and controlling inflammation and autoimmunity, with the cytokine interleukin-2 (IL-2) playing a key role in their growth and survival. Many autoimmune and rheumatic diseases show disruptions in Treg biology, leading to an imbalance between protective and pathogenic immune cells. Low-dose IL-2 therapy aims to restore physiological balance by compensating for IL-2 deficiency and strengthening the Treg population to counteract inflammation effectively.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

Regulatory T Cells in Autoimmunity and Cancer: A Duplicitous Lifestyle

Aikaterini Hatzioannou et al.

Summary: Treg cell plasticity plays a significant role in autoimmunity and cancer, characterized by loss of Foxp3 expression. It has great therapeutic potential through destabilizing Treg cells to promote anti-tumor immunity or enhancing Treg cell stability to attenuate chronic inflammation.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

Regulatory T Cells and Human Disease

Shimon Sakaguchi et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)

Review Oncology

Deptor: not only a mTOR inhibitor

Valeria Catena et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)

Review Pediatrics

Regulatory T Cells in Allergy and Asthma

Elena Martin-Orozco et al.

FRONTIERS IN PEDIATRICS (2017)

Article Immunology

Low-Dose IL-2 Induces Regulatory T Cell-Mediated Control of Experimental Food Allergy

Benjamin Bonnet et al.

JOURNAL OF IMMUNOLOGY (2016)

Article Immunology

An essential role for the IL-2 receptor in Treg cell function

Takatoshi Chinen et al.

NATURE IMMUNOLOGY (2016)

Review Cell Biology

The role of cullin 5-containing ubiquitin ligases

Fumihiko Okumura et al.

CELL DIVISION (2016)

Review Immunology

The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases

David Klatzmann et al.

NATURE REVIEWS IMMUNOLOGY (2015)

Article Biochemistry & Molecular Biology

Regulation of Janus kinases by SOCS proteins

Nadia J. Kershaw et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2013)

Article Biochemistry & Molecular Biology

SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition

Nadia J. Kershaw et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)

Editorial Material Cell Biology

mTOR Signaling

Mathieu Laplante et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)

Review Immunology

CD4+FOXP3+ T Regulatory Cells in Human Autoimmunity: More Than a Numbers Game

S. Alice Long et al.

JOURNAL OF IMMUNOLOGY (2011)

Article Biotechnology & Applied Microbiology

Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling

Guoqiang Xu et al.

NATURE BIOTECHNOLOGY (2010)

Article Multidisciplinary Sciences

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

Teresa A. Soucy et al.

NATURE (2009)

Review Immunology

The role of E3 ligases in autoimmunity and the regulation of autoreactive T cells

Amy Erica Lin et al.

CURRENT OPINION IN IMMUNOLOGY (2007)

Article Biochemistry & Molecular Biology

GRAIL is up-regulated in CD4+ CD25+ T regulatory cells and is sufficient for conversion of T cells to a regulatory phenotype

Debra A. MacKenzie et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Immunology

Two isoforms of otubain 1 regulate T cell anergy via GRAIL

L Soares et al.

NATURE IMMUNOLOGY (2004)